Carlsmed, Inc.

CARL Nasdaq SEC CIK 1794546
Follow Carlsmed Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $21.6M +64.9% vs same quarter last year
Net income −$12.2M −43.6% vs same quarter last year
EPS, diluted −$0.45 −12.5% vs same quarter last year
Operating cash flow −$8.7M −2.5% vs same quarter last year
Revenue by quarter
$9.4M
$10.2M
$12.1M
$13.1M
$15.2M
$16.1M
$18.9M
$21.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing